Recent Articles By The Author
Outperforming the Nasdaq Ain't What It Used to Be
Nasdaq's fall shows that the indices aren't the best benchmarks for your fund's performance.
Take Your Funds' April 14 Performance as a Sign of Future Risk
That one-day return is a key indicator and much easier to absorb than beta or standard deviation.
The Cutting Room: Biotech or Internet?
Or is it just a popularity contest between JJC and the Chartman? Either way, you decide.
When to Sell Your Fund: A Guide
Should you sell that loser or wait for it to turn around? Here's some help in making that choice.